In the low-intermediate risk group (Gleason 7, prostate-specific antigen, <10 ng/mL or Gleason 6, prostate-specific antigen, 10 to 20 ng/mL) low-dose brachytherapy alone can be offered as monotherapy.

Interstitial brachytherapy uses slightly radioactive particles implanted into the prostate to deliver radiation directly to the tumour (low-dose-rate, LDR).

Brachytherapy for high-risk prostate cancers patients has historically been considered a less effective modality, but a new study from radiation oncologists at the Kimmel Cancer Center at ...

To assess the risk of second primary cancer (SPC) after [125 I]iodine prostate cancer brachytherapy compared with prostatectomy and the general population. Patients and Methods In a cohort consisting ...

Prostate brachytherapy (BT) is a form of radiation therapy used to treat prostate cancer. The technique involves placing encapsulated radioisotopes inside or nearby the tumor.

Zhou Z, Yan W, Zhou Y, et al.125I low-dose-rate prostate brachytherapy and radical prostatectomy in patients with prostate cancer. Oncol Lett. 2019;18:72-80. doi: 10.3892/ol.2019.10279 .

Intermediate risk prostate cancer may be well controlled with brachytherapy alone. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2016 / 09 / 160926143022.htm ...

Prostate brachytherapy, or seeding, is radiation inside the prostate achieved by placing radioactive isotopes at precise sites. These are low-energy radioactive sources such as Palladium-103 or ...

Billing and coding is also another important factor to address when considering adding prostate brachytherapy. It’s a complex billing methodology. Where most procedures involve just a few CPT codes, ...

A highly effective and “minimally invasive” prostate cancer treatment is “disappearing” from private hospitals in New Zealand ...

Typically, brachytherapy is used for men with early-stage prostate cancer that is relatively low-grade, or combined with EBRT for men who have a higher risk of the cancer growing outside the ...

However, because of ionizing radiation, brachytherapy may cause radiation-induced second primary cancer (SPC). For prostate cancer, most research on radiation-induced SPCs has been performed after ...